Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 998

1.

Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.

Reiss TF, Chervinsky P, Dockhorn RJ, Shingo S, Seidenberg B, Edwards TB.

Arch Intern Med. 1998 Jun 8;158(11):1213-20.

PMID:
9625400
[PubMed - indexed for MEDLINE]
2.

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.

Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, Michele TM, Reiss TF, Nguyen HH, Bratton DL.

Pediatrics. 2001 Sep;108(3):E48.

PMID:
11533366
[PubMed - indexed for MEDLINE]
3.

Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group.

Malmstrom K, Rodriguez-Gomez G, Guerra J, Villaran C, Piñeiro A, Wei LX, Seidenberg BC, Reiss TF.

Ann Intern Med. 1999 Mar 16;130(6):487-95.

PMID:
10075616
[PubMed - indexed for MEDLINE]
4.

Effect of montelukast, a once-daily leukotriene receptor antagonist, on peak expiratory flow variability.

Zhang J, Yu C, Noonan G, Reiss TF.

Clin Ther. 2002 Apr;24(4):574-82.

PMID:
12017402
[PubMed - indexed for MEDLINE]
5.

A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group.

Altman LC, Munk Z, Seltzer J, Noonan N, Shingo S, Zhang J, Reiss TF.

J Allergy Clin Immunol. 1998 Jul;102(1):50-6.

PMID:
9679847
[PubMed - indexed for MEDLINE]
6.

Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).

Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening A, Haahtela T, Holgate ST, Picado C, Leff JA.

Respir Med. 2000 Jun;94(6):612-21.

PMID:
10921768
[PubMed - indexed for MEDLINE]
Free Article
7.

Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.

Leff JA, Busse WW, Pearlman D, Bronsky EA, Kemp J, Hendeles L, Dockhorn R, Kundu S, Zhang J, Seidenberg BC, Reiss TF.

N Engl J Med. 1998 Jul 16;339(3):147-52.

PMID:
9664090
[PubMed - indexed for MEDLINE]
Free Article
8.

Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma.

Reicin A, White R, Weinstein SF, Finn AF Jr, Nguyen H, Peszek I, Geissler L, Seidenberg BC.

Arch Intern Med. 2000 Sep 11;160(16):2481-8.

PMID:
10979060
[PubMed - indexed for MEDLINE]
9.

Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients.

Tohda Y, Fujimura M, Taniguchi H, Takagi K, Igarashi T, Yasuhara H, Takahashi K, Nakajima S.

Clin Exp Allergy. 2002 Aug;32(8):1180-6.

PMID:
12190656
[PubMed - indexed for MEDLINE]
10.

Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older.

Williams B, Noonan G, Reiss TF, Knorr B, Guerra J, White R, Matz J.

Clin Exp Allergy. 2001 Jun;31(6):845-54.

PMID:
11422148
[PubMed - indexed for MEDLINE]
11.

Montelukast: a review of its therapeutic potential in persistent asthma.

Jarvis B, Markham A.

Drugs. 2000 Apr;59(4):891-928. Review.

PMID:
10804041
[PubMed - indexed for MEDLINE]
12.

Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients.

Dockhorn RJ, Baumgartner RA, Leff JA, Noonan M, Vandormael K, Stricker W, Weinland DE, Reiss TF.

Thorax. 2000 Apr;55(4):260-5.

PMID:
10722763
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma.

Price DB, Hernandez D, Magyar P, Fiterman J, Beeh KM, James IG, Konstantopoulos S, Rojas R, van Noord JA, Pons M, Gilles L, Leff JA; Clinical Outcomes with Montelukast as a Partner Agent to Corticosteroid Therapy (COMPACT) International Study Group.

Thorax. 2003 Mar;58(3):211-6.

PMID:
12612295
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma.

Reiss TF, Altman LC, Chervinsky P, Bewtra A, Stricker WE, Noonan GP, Kundu S, Zhang J.

J Allergy Clin Immunol. 1996 Sep;98(3):528-34.

PMID:
8828530
[PubMed - indexed for MEDLINE]
15.

Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity.

Busse WW, Casale TB, Dykewicz MS, Meltzer EO, Bird SR, Hustad CM, Grant E, Zeldin RK, Edelman JM.

Ann Allergy Asthma Immunol. 2006 Jan;96(1):60-8.

PMID:
16440534
[PubMed - indexed for MEDLINE]
16.

Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma.

Vaquerizo MJ, Casan P, Castillo J, Perpiña M, Sanchis J, Sobradillo V, Valencia A, Verea H, Viejo JL, Villasante C, Gonzalez-Esteban J, Picado C; CASIOPEA (Capacidad de Singulair Oral en la Prevencion de Exacerbaciones Asmaticas) Study Group.

Thorax. 2003 Mar;58(3):204-10. Erratum in: Thorax. 2003 Apr;58(4):370.

PMID:
12612294
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study.

Ilowite J, Webb R, Friedman B, Kerwin E, Bird SR, Hustad CM, Edelman JM.

Ann Allergy Asthma Immunol. 2004 Jun;92(6):641-8.

PMID:
15237766
[PubMed - indexed for MEDLINE]
19.

Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial.

Robinson DS, Campbell D, Barnes PJ.

Lancet. 2001 Jun 23;357(9273):2007-11.

PMID:
11438132
[PubMed - indexed for MEDLINE]
20.

Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids.

Wilson AM, Dempsey OJ, Sims EJ, Lipworth BJ.

Chest. 2001 Apr;119(4):1021-6.

PMID:
11296164
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk